Medical News

Medical news update

  • Error in Affiliations

    The Brief Report “Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial,” published in the June 2021 issue of JAMA Cardiology, […]

  • Evaluating Pregnancy Safety During Cardiology Training

    This survey study of women who were pregnant during cardiology fellowship assesses health and safety measures implemented during pregnancy.

  • Rethinking Anticoagulation for Left Atrial Appendage Closure

    The optimal antithrombotic therapy (ATT) regimen to prevent device-related thrombosis (DRT) while not increasing bleeding risk after percutaneous left atrial appendage occlusion (LAAO) is unclear. […]

  • Changing the Frame of Post-AMI Left Ventricular Dysfunction

    Left ventricular (LV) dysfunction, as an abrupt occurrence due to acute myocardial infarction (AMI), or as a chronic pathology in the setting of heart failure, represents a known risk factor and […]

  • JAMA Cardiology

    Mission Statement: JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, […]

  • Noninvasive Visualization of the Atrioventricular Conduction System

    This cohort study investigates if contrast-enhanced cardiac computed tomography can localize the atrioventricular conduction system through the identification of the insular fat of the conductive […]

  • Heart Failure—Together We Go Farther—Reply

    In Reply We thank Van der Linden and Mullens for their interest in our recent Review article on quality improvement interventions for optimization of guideline-directed medical therapy (GDMT). We […]

  • Leadless Ultrasound-Based Cardiac Resynchronization Therapy

    Cardiovascular electronic implantable devices are an important and often necessary treatment for patients with symptomatic bradycardia, heart failure, and those at risk for recurrent ventricular […]

  • ESH 2025

    Milan - May 23-26 MICO Congresso Center

  • ESH Webinars 2024

    PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities

  • ESH Webinars 2024

    Part I - February 20, 2024 | 17:00 (CET) Part II - March 19, 2024 | 17:00 (CET)

  • ESH 2024

    BERLIN MAY 31 - JUNE 3, 2024 www.eshannualmeetings.eu Abstracts are available in Journal of Hypertension

  • NEW EUROPEAN GUIDELINES

    The final version of the full guidelines is now available on the Journal of Hypertension website.

  • Webinar series

    HOT TOPICS IN HYPERTENSION MANAGEMENT - AUTUMN 2020 (Part 2) - NOW AVAILABLE.

  • ESH Online Education

    The European Society of Hypertension is pleased to announce the updated version of the ESH e-Learning Hypertension Self-Assessment Programme is now available.

  • Test article 2

    At solmen va esser necessi far uniform grammatica, pronunciation e plu sommun paroles.